J&J deals Cordis to Cardinal Health for nearly $2B
March 2, 2015 by Brad Perriello
Healthcare giant Johnson & Johnson confirmed that it plans to deal its Cordis stent-making arm to Cardinal Health for $1.94 billion.
The deal, which is worth some $1.59 billion net of tax benefits, is expected to close near the end of the year and offers annual synergies in excess of $100 million by the end of fiscal 2018, Cardinal Health said. Read more
UPDATE: Cyberonics to buy Italy's Sorin for $1.4B
February 26, 2015 by MassDevice
Cyberonics agreed to buy Sorin Group in an all-stock deal that the Italian company said values it at about $1.4 billion.
The new group will bring together 2 global leaders in the growing markets of cardiac surgery and neuromodulation, with a combined equity value of $2.7 billion, the companies said in a joint statement today. Read more
Confirmed: Boston Scientific to buy Endo's urology portfolio for $1.65B
March 2, 2015 by Brad Perriello
Endo International and Boston Scientific confirmed reports of a $1.65 billion acquisition of Endo’s American Medical Systems urology business.
The companies said the deal, expected to close during the 3rd quarter, does not include AMS’s star-crossed pelvic mesh assets, for which Endo said it’s “evaluating strategic alternatives.” Read more
Nikon pushes into medtech with $400 mln Optos acquisition
February 27, 2015 by MassDevice
Nikon, the 98-year-old Japanese company best known for its cameras, has agreed to buy British retinal imaging firm Optos for 259.3 million pounds ($400 million) as it moves into the medical sector.
Nikon has previously said it intended to enter the medical sector to leverage its optical technologies and the Japanese group sees buying Optos as an important step in that long-term growth plan. Read more
Report: Allergan CEO in line for $100M payout from Actavis deal
February 25, 2015 by Mark Hollmer
Allergan Chairman and CEO David Pyott stands to earn $100 million once its multi-billion-dollar merger with Actavis is consummated later this year.
The Orange County Business Journal, citing a federal regulatory filing, detailed the big payout coming for Pyott. He’ll get $89 million in cash and stock of the combined company, as well as other payments, but he must also give up unvested equity awards, according to the story. Read more
